Applied Genetic Technologies (NASDAQ:AGTC) is scheduled to be releasing its earnings data after the market closes on Tuesday, November 12th. Analysts expect Applied Genetic Technologies to post earnings of ($0.58) per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.
Applied Genetic Technologies (NASDAQ:AGTC) last issued its quarterly earnings results on Thursday, September 26th. The biotechnology company reported ($0.58) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.54) by ($0.04). Applied Genetic Technologies had a negative return on equity of 2.49% and a negative net margin of 4.81%. The business had revenue of $0.41 million for the quarter, compared to analysts’ expectations of $0.71 million. On average, analysts expect Applied Genetic Technologies to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
Shares of Applied Genetic Technologies stock opened at $3.08 on Friday. The business’s fifty day moving average is $3.30 and its two-hundred day moving average is $3.65. The firm has a market cap of $58.85 million, a PE ratio of -28.00 and a beta of 2.58. Applied Genetic Technologies has a fifty-two week low of $2.26 and a fifty-two week high of $7.48.
Applied Genetic Technologies Company Profile
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's lead products consist of four ophthalmology development programs across three targets, including X-linked retinoschisis that is in Phase I/II clinical trials; X-linked retinitis pigmentosa, which is in Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials for the treatment of inherited retinal diseases, as well as a preclinical program in adrenoleukodystrophy, which is a disease of the central nervous system and otology.
Featured Story: What Does Beta Mean In Stock Selection?
Receive News & Ratings for Applied Genetic Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Genetic Technologies and related companies with MarketBeat.com's FREE daily email newsletter.